| AKR1B10 |
| LOCUS ID | 57016 | ||||||||||
| GENE_SYMBOL | AKR1B10 | ||||||||||
| GENE NAME | aldo-keto reductase | ||||||||||
| SYNONYMNS | HIS, HSI, ARL1, ARL-1, ALDRLn, AKR1B11, AKR1B12 | ||||||||||
| CHROMOSOME | 7 | ||||||||||
| HOMOLOGENE ID | 116462 |
| microRNAs | NA | NA |
| GENE SUMMARY |
|---|
| This gene encodes a member of the aldo/keto reductase superfamily, which consists of more than 40 known enzymes and proteins. This member can efficiently reduce aliphatic and aromatic aldehydes, and it is less active on hexoses. It is highly expressed in adrel gland, small intestine, and colon, and may play an important role in liver carcinogenesi |
| OBSERVATIONS |
|---|
| Complication | Evidence | PMID |
| Nephropathy | 1. Under high glucose and LPS conditions, there was a significant increase in the expression of AKR1B10 in the PBMCs from patients with DN compared to those without DN and the normal controls. In conclusion, these results suggest that AKR1B10 may have an important role in the development and progression of DN. | 23975544 |